LAG3 and Miyoshi myopathy: LAG3 rs870849 was prevalent at elevated allele frequencies in MM patients eligible for ASCT, with MAF 0.61 in male and MAF 0.53 in female MM patients compared to MAF 0.39 in the general European population, and MAF 0.45 in the African and African American population.